Northeast Biodefense Center requests applications for countermeasure research projects

The Northeast Biodefense Center recently announced a request for applications for a program to support research in areas related to creating new therapeutics, vaccines and diagnostics against threatening biological agents.

The NBC, one of the National Institute of Allergy and Infectious Diseases' Regional Centers for Excellence for Biodefense and Emerging Infectious Diseases, is soliciting the applications as part of its Developmental Projects Program. The DPP funds early-stage research projects that have the potential of developing into more substantive programs.

The goal of the program is to promote research that could develop countermeasures to combat Category A through C select agents or other emerging infectious pathogens. The DPP will invest in initiatives that have the most potential for growing into projects that could compete for funding through the National Institutes of Health. The program will fund higher-risk research and require less preliminary data than standard RO1 grants.

The DPP will provide support for projects for up to 18 months. The program is seeking to bring in investigators not already working in biodefense and not already participating in the NBC.

The program encourages collaborations between investigators and will give special consideration to investigators with unique insights or methods. The DPP will grant one-year funding at a maximum of $125,000 per year in direct costs with a budget of $150,000 per year possible if the project involves specialized reagents or state-of-the-art technologies.

Organizations in this Story

National Institutes of Health

Want to get notified whenever we write about National Institutes of Health ?
Next time we write about National Institutes of Health, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.